Study shows how PBS drives cancer care

Changes in PBS restrictions have had a dramatic impact on the type of endocrine therapy breast cancer patients are likely to receive, new research finds.

The study looked at endocrine therapy prescriptions for over 1,200 NSW women with hormone-dependent early breast cancer.

It revealed a sharp difference in the proportion of post-menopausal women who received the recommended treatment before and after changes in 2006 which made aromatase inhibitors (AIs) more affordable.

Although AIs are the gold standard treatment